Recent research also showed that genes including ACTN1 and TNFAIP2 play significant roles in tumor progression and CT resistance, suggesting ACTN1 as a novel target in HNSCC.96, 97. This evidence concerns the gene ACTN1 and head and neck squamous cell carcinoma.